| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 03/18/2010 | WO2010030722A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 03/18/2010 | WO2010029996A1 Pharmaceutical composition |
| 03/18/2010 | WO2010029995A1 Therapeutic agent for pain |
| 03/18/2010 | US20100069641 Process for the preparation of sodium salt of 1-(((1(r)-(3-(2-(7-chloro-2-quinolinyl)-ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)sulfanyl)methyl)cyclopropaneacetic acid |
| 03/18/2010 | US20100069414 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 03/18/2010 | US20100069405 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 03/18/2010 | US20100069379 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 03/18/2010 | US20100069367 LXR and FXR Modulators |
| 03/18/2010 | US20100069366 Antibacterial quinoline derivatives |
| 03/18/2010 | US20100068786 Methods and compositions for reversing p-glycoprotein medicated drug resistance |
| 03/18/2010 | US20100068752 Novel fluorescent dyes and compounds, methods and kits useful for identifying specific organelles and regions in cells of interest |
| 03/18/2010 | US20100068553 Ultra-thin hydrophobic and oleophobic layer, method of manufacture and use in watchmaking as an epilame |
| 03/18/2010 | US20100068288 Mixtures or organic compounds for the treatment of airway diseases |
| 03/18/2010 | US20100068204 4-aryloxyquinolin-2(1h)-ones as mtor kinase and pi3 kinase inhibitors, for use as anti-cancer agents |
| 03/17/2010 | EP2162437A1 Enrofloxacin-hexahydrate |
| 03/17/2010 | EP2162135A1 Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents |
| 03/17/2010 | EP1713822B1 Hcv ns-3 serine protease inhibitors |
| 03/17/2010 | EP1031569B1 Salt of a 7-isoindolinequinolonecarboxylic acid derivative, monohydrate thereof and composition containing the same as active ingredient |
| 03/17/2010 | CN101675054A Cyclopamine lactam analogs and methods of use thereof |
| 03/17/2010 | CN101671302A Production process of enrofloxacin antibacterial drug for fowl and livestock |
| 03/17/2010 | CN101671301A Heterocyclic substituent acardite derivate and application thereof |
| 03/17/2010 | CN101671257A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 03/17/2010 | CN101671227A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 03/16/2010 | US7678913 Ureas as factor Xa inhibitors |
| 03/16/2010 | US7678912 oxidation of 1-Isobutyl-1H-imidazo quinoline afforded 1-Isobutyl-1H-imidazo-[4,5-c]-quinoline-5-N-oxide which is isolated in pure form as its hydrochloride salt followed by conversion to 4-chloro derivative and conversion to corresponding 4-iodo derivative which is a new intermediate |
| 03/16/2010 | US7678831 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis |
| 03/16/2010 | US7678814 Aroyl-piperidine derivatives |
| 03/16/2010 | US7678812 Aminotetralin-derived urea modulators of vanilloid VR1 receptor |
| 03/16/2010 | US7678811 An urea compounds containing a pyridine, quinoline, or isoquinoline functionality; p38 mediated diseases such as inflammation and VEGF mediated diseases such as angogenesis disorders |
| 03/11/2010 | WO2010028015A2 2-oxo-1,2-dihydro-quinoline modulators of immune function |
| 03/11/2010 | WO2010027150A2 New preparation of hydroxychloroquine |
| 03/11/2010 | WO2010027060A1 Process for producing 3,5-dihydroxy-6-heptenoic acid amine salt |
| 03/11/2010 | WO2010026771A1 Nitrogenated heterocyclic compound and salt thereof, and bactericidal agent for agricultural or horticultural applications |
| 03/11/2010 | WO2009050734A9 An industrially feasible process for the manufacture of bisquinoline derivatives by using substantially pure n-monosubstituted piperazines |
| 03/11/2010 | US20100063291 Process for preparation of solid montelukast |
| 03/11/2010 | US20100063282 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions, and Uses Thereof |
| 03/11/2010 | US20100063279 Method for producing quinolone carboxylic acid derivative |
| 03/11/2010 | US20100063061 Antibacterial quinoline derivatives |
| 03/11/2010 | US20100063026 Antibacterial quinoline derivatives |
| 03/11/2010 | US20100061928 Labelled analogues of halobenzamides as radiopharmaceuticals |
| 03/11/2010 | CA2736091A1 2-oxo-1,2-dihydro-quinoline modulators of immune function |
| 03/10/2010 | EP2161258A2 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| 03/10/2010 | CN101668745A Process for the preparation of optically active ethenylphenyl alcohols |
| 03/09/2010 | US7674909 Tetrahydroquinoline derivatives and their use as FSH receptor modulators |
| 03/09/2010 | US7674809 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production |
| 03/09/2010 | US7674805 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 03/09/2010 | CA2336702C Sulfonylaminocarboxylic acid n-arylamides as guanylate cyclase activators |
| 03/09/2010 | CA2306313C Dipeptide nitriles |
| 03/04/2010 | WO2009117484A3 Small molecule e2f inhibitor |
| 03/04/2010 | US20100056793 Process for pure montelukast sodium through pure intermediates as well as novel amine salts |
| 03/04/2010 | US20100056783 Novel Process for the Preparation of Statins and their Pharmaceutically Acceptable Salts thereof |
| 03/04/2010 | US20100056570 Fungicides |
| 03/04/2010 | US20100056507 Phenyl derivatives and their use as a medicament |
| 03/04/2010 | US20100056504 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester- introduced phenyl group as substituents |
| 03/04/2010 | US20100055072 2-oxo-1,2-dihydro-quinoline modulators of immune function |
| 03/03/2010 | EP2159216A1 Ih - Modulators |
| 03/03/2010 | EP2158183A2 Ion channel modulators and methods of use |
| 03/02/2010 | US7671214 Modification of the indolium ring to permit a reactive group or conjugated substance at the 3 ring position unexpectedly mitigates the problems of quenching, difficulty in preparing, strong tendency to self-associate (stack); fluorescent dyes; biomarking; uniformity; intensity; photostability |
| 03/02/2010 | US7671205 6-aminoisoquinoline compounds |
| 03/02/2010 | US7671074 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others; N-{amino-[pyridin-2-yl-methyl)-amino]-methylene}-4-methylbenzenesulfonamide |
| 03/02/2010 | US7671032 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV) |
| 02/25/2010 | WO2010021882A2 Cold menthol receptor antagonists |
| 02/25/2010 | WO2009151683A3 Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications |
| 02/25/2010 | WO2009148659A3 Antimalarial quinolines and methods of use thereof |
| 02/25/2010 | WO2009110985A3 Amide compounds, compositions and uses thereof |
| 02/25/2010 | US20100048893 Substituted arylalkanoic acid derivatives and use thereof |
| 02/25/2010 | US20100048621 Medicament for treating chronic obstructive pulmonary disease |
| 02/25/2010 | US20100048620 Composition for treatment of undifferentiated gastric cancer |
| 02/25/2010 | US20100048589 Cold Menthol Receptor Antagonists |
| 02/25/2010 | US20100048585 Quinoline derivatives as antibacterial agents |
| 02/25/2010 | US20100048566 Antibacterial quinoline derivatives |
| 02/25/2010 | US20100048540 Heterocyclic N-Oxides as Hypoxic Selective Protein Kinase Inhibitors |
| 02/25/2010 | CA2735130A1 Compounds and methods for treating respiratory diseases |
| 02/24/2010 | EP2155776A2 Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof |
| 02/24/2010 | EP2155643A1 Ire-1a inhibitors |
| 02/24/2010 | EP2155194A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/24/2010 | EP2029596B1 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same |
| 02/24/2010 | EP1000999B1 Compounds for organic el devices and organic el devices |
| 02/24/2010 | CN101654435A N-benzyl quinoline carboxylic acid compound, combination and preparation method thereof |
| 02/24/2010 | CN101654434A Process for the manufacture of organic compounds |
| 02/23/2010 | USRE41150 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors; compounds based on thieno(4,3,2-ef)(2)benzazepin-6-one |
| 02/23/2010 | USRE41149 Optically active pyridonecarboxylic acid derivatives |
| 02/23/2010 | US7666619 Compounds and methods for regulating bacterial growth and pathogenesis |
| 02/23/2010 | US7666608 Determining ratio of expression levels of serum amyloid A1 (SAA1) gene and serum amyloid A2 (SAA2) gene; steroid treatment prognosis; tumor necrosis factor inhibitors |
| 02/23/2010 | CA2345146C Cyanophenyl derivative |
| 02/18/2010 | WO2010019473A1 Aurora kinase modulators and methods of use |
| 02/18/2010 | WO2010018555A2 Quinoline compounds containing a dibemethin group |
| 02/18/2010 | WO2010018547A1 Aminoquinoline compounds |
| 02/18/2010 | WO2009049716A8 Novel fungicides |
| 02/18/2010 | WO2009030469A8 Fungicidal 2-alkylthio-2-quinolinyloxy-acetamide deritvatives |
| 02/18/2010 | WO2008062478A3 Improved process for pure montelukast sodium through pure intermediates as well as novel amine salts |
| 02/18/2010 | WO2008035379A3 Process for and intermediates of leukotriene antagonists |
| 02/18/2010 | US20100041699 Microcrystalline (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl) acetic acid |
| 02/18/2010 | US20100041698 Heterocyclic compounds and their use as binding partners for 5-ht5 receptors |
| 02/18/2010 | US20100041694 Agricultural composition for controlling or preventing plant diseases caused by plant pathogenic microbes |
| 02/18/2010 | US20100041656 Novel amide derivatives and medicinal use thereof |
| 02/18/2010 | US20100041653 Composition and methods for the design and development of metallo-enzyme inhibitors |
| 02/17/2010 | EP2154132A1 A process for preparing tetrahydroquinoline derivatives |
| 02/17/2010 | EP2152699A1 Quinolone compound and pharmaceutical composition |
| 02/17/2010 | EP2152672A1 Novel sulphoximine-substituted quinazoline and quinazoline derivatives as kinase inhibitors |